Research ArticleBRAIN
Posterior Reversible Encephalopathy Syndrome after Solid Organ Transplantation
W.S. Bartynski, H.P. Tan, J.F. Boardman, R. Shapiro and J.W. Marsh
American Journal of Neuroradiology May 2008, 29 (5) 924-930; DOI: https://doi.org/10.3174/ajnr.A0960
W.S. Bartynski
H.P. Tan
J.F. Boardman
R. Shapiro
References
- ↵Truwit CL, Denaro CP, Lake JR, et al. MR imaging of reversible cyclosporin A-induced neurotoxicity. AJNR Am J Neuroradiol 1991;12:651–59
- ↵
- ↵Bartynski WS, Zeigler Z, Spearman MP, et al. Etiology of cortical and white matter lesions in cyclosporin-A and FK-506 neurotoxicity. AJNR Am J Neuroradiol 2001;22:1901–14
- ↵Covarrubias DJ, Luetmer PH, Campeau NG. Posterior reversible encephalopathy syndrome: prognostic utility of quantitative diffusion-weighted MR images. AJNR Am J Neuroradiol 2002;23:1038–48
- Hinchey J, Chaves C, Appignani B, et al. A reversible posterior leukoencephalopathy syndrome. N Engl J Med 1996;334:494–500
- ↵Mukherjee P, McKinstry RC. Reversible posterior leukoencephalopathy syndrome: evaluation with diffusion-tensor MR imaging. Radiology 2001;219:756–65
- ↵Provenzale JM, Petrella JR, Cruz LC Jr, et al. Quantitative assessment of diffusion abnormalities in posterior reversible encephalopathy syndrome. AJNR Am J Neuroradiol 2001;22:1455–61
- ↵Besenski N, Rumboldt Z, Emovon O, et al. Brain MR imaging abnormalities in kidney transplant recipients. AJNR Am J Neuroradiol 2005;26:2282–89
- ↵Appignani BA, Bhadelia RA, Blacklow SC, et al. Neuroimaging findings in patients on immunosuppressive therapy: experience with tacrolimus toxicity. AJR Am J Roentgenol 1996;166:683–88
- Parvex P, Pinsk M, Bell LE, et al. Reversible encephalopathy associated with tacrolimus in pediatric renal transplants. Pediatr Nephrol 2001;16:537–42
- Thyagarajan GK, Cobanoglu A, Johnston W. FK506-induced fulminant leukoencephalopathy after single-lung transplantation. Ann Thorac Surg 1997;64:1461–64
- ↵Bartynski WS, Sanghvi A. Neuroimaging of delayed eclampsia. Report of 3 cases and review of the literature. J Comput Assist Tomogr 2003;27:699–713
- Ito T, Sakai T, Inagawa S, et al. MR angiography of cerebral vasospasm in preeclampsia. AJNR Am J Neuroradiol 1995;16:1344–46
- ↵Schaefer PW, Buonanno FS, Gonzalez RG, et al. Diffusion-weighted imaging discriminates between cytotoxic and vasogenic edema in a patient with eclampsia. Stroke 1997;28:1082–85
- ↵Singh N, Bonham A, Fukui M. Immunosuppressive-associated leukoencephalopathy in organ transplant recipients. Transplantation 2000;69:467–72
- ↵Bartynski WS, Boardman JF, Zeigler ZR, et al. Posterior reversible encephalopathy syndrome in infection, sepsis, and shock. AJNR Am J Neuroradiol 2006;27:2179–90
- ↵Schwartz RB, Bravo SM, Klufas RA, et al. Cyclosporine neurotoxicity and its relationship to hypertensive encephalopathy: CT and MR findings in 16 cases. AJR Am J Roentgenol 1995;165:627–31
- Kur JK, Esdaile JM. Posterior reversible encephalopathy syndrome–an underrecognized manifestation of systemic lupus erythematosus. J Rheumatol 2006;33:2178–83
- Poon WL, Mok CC. Reversible posterior leucoencephalopathy in scleroderma. Ann Rheum Dis 2005;64:1803–04
- ↵Glusker P, Recht L, Lane B. Reversible posterior leukoencephalopathy syndrome and bevacizumab. N Engl J Med 2006;354:980–82; discussion 980–982
- Ito Y, Arahata Y, Goto Y, et al. Cisplatin neurotoxicity presenting as reversible posterior leukoencephalopathy syndrome. AJNR Am J Neuroradiol 1998;19:415–17
- Ozcan C, Wong SJ, Hari P. Reversible posterior leukoencephalopathy syndrome and bevacizumab. N Engl J Med 2006;354:980–82; discussion 980–982
- Patel AG, Rao R. Transient Ara-C leukoencephalopathy: MR findings. J Comput Assist Tomogr 1996;20:161–62
- Rippe DJ, Edwards MK, Schrodt JF, et al. Reversible cerebral lesions associated with tiazofurin usage: MR demonstration. J Comput Assist Tomogr 1988;12:1078–81
- ↵Russell MT, Nassif AS, Cacayorin ED, et al. Gemcitabine-associated posterior reversible encephalopathy syndrome: MR imaging and MR spectroscopy findings. Magn Reson Imaging 2001;19:129–32
- ↵Gijtenbeek JM, van den Bent MJ, Vecht CJ. Cyclosporine neurotoxicity: a review. J Neurol 1999;246:339–46
- ↵Ay H, Buonanno FS, Schaefer PW, et al. Posterior leukoencephalopathy without severe hypertension: utility of diffusion-weighted MRI. Neurology 1998;51:1369–76
- ↵Sibai BM. Eclampsia. VI. Maternal-perinatal outcome in 254 consecutive cases. Am J Obstet Gynecol 1990;163:1049–54; discussion 1054–55
- ↵Bartynski WS, Boardman JF. Distinct imaging patterns and lesion distribution in posterior reversible encephalopathy syndrome. AJNR Am J Neuroradiol 2007;28:1320–27
- ↵Bartynski WS, Zeigler ZR, Shadduck RK, et al. Pretransplantation conditioning influence on the occurrence of cyclosporine or FK-506 neurotoxicity in allogeneic bone marrow transplantation. AJNR Am J Neuroradiol 2004;25:261–69
- ↵
- ↵Jain A, Brody D, Hamad I, et al. Conversion to Neoral for neurotoxicity after primary adult liver transplantation under tacrolimus. Transplantation 2000;69:172–76
- ↵Brubaker LM, Smith JK, Lee YZ, et al. Hemodynamic and permeability changes in posterior reversible encephalopathy syndrome measured by dynamic susceptibility perfusion-weighted MR imaging. AJNR Am J Neuroradiol 2005;26:825–30
- Engelter ST, Provenzale JM, Petrella JR. Assessment of vasogenic edema in eclampsia using diffusion imaging. Neuroradiology 2000;42:818–20
- Naidu K, Moodley J, Corr P, et al. Single photon emission and cerebral computerised tomographic scan and transcranial Doppler sonographic findings in eclampsia. Br J Obstet Gynaecol 1997;104:1165–72
- Lin JT, Wang SJ, Fuh JL, et al. Prolonged reversible vasospasm in cyclosporin A-induced encephalopathy. AJNR Am J Neuroradiol 2003;24:102–04
- Raps EC, Galetta SL, Broderick M, et al. Delayed peripartum vasculopathy: cerebral eclampsia revisited. Ann Neurol 1993;33:222–25
- Trommer BL, Homer D, Mikhael MA. Cerebral vasospasm and eclampsia. Stroke 1988;19:326–29
- ↵Raroque HG, Jr., Orrison WW, Rosenberg GA. Neurologic involvement in toxemia of pregnancy: reversible MRI lesions. Neurology 1990;40:167–69
- ↵Bonham CA, Dominguez EA, Fukui MB, et al. Central nervous system lesions in liver transplant recipients: prospective assessment of indications for biopsy and implications for management. Transplantation 1998;66:1596–604
- ↵Cilio MR, Danhaive O, Gadisseux JF, et al. Unusual cyclosporin related neurological complications in recipients of liver transplants. Arch Dis Child 1993;68:405–07
- ↵Bohlin AB, Berg U, Englund M, et al. Central nervous system complications in children treated with ciclosporin after renal transplantation. Child Nephrol Urol 1990;10:225–30
- de Groen PC, Aksamit AJ, Rakela J, et al. Central nervous system toxicity after liver transplantation. The role of cyclosporine and cholesterol. N Engl J Med 1987;317:861–66
- ↵Deierhoi MH, Kalayoglu M, Sollinger HW, et al. Cyclosporine neurotoxicity in liver transplant recipients: report of three cases. Transplant Proc 1988;20:116–18
- ↵Reece DE, Frei-Lahr DA, Shepherd JD, et al. Neurologic complications in allogeneic bone marrow transplant patients receiving cyclosporin. Bone Marrow Transplant 1991;8:393–401
- ↵Zimmer WE, Hourihane JM, Wang HZ, et al. The effect of human leukocyte antigen disparity on cyclosporine neurotoxicity after allogeneic bone marrow transplantation. AJNR Am J Neuroradiol 1998;19:601–08; discussion 609–10
- ↵
- ↵Burt RK, Wilson WH. Conditioning (preparative) regimens. In: Burt RK, Deeg HJ, Lothian ST, Santos GW, eds. Bone Marrow Transplant. Georgetown, Tex: Landes Bioscience;1996 :94–108
- ↵
- ↵Chew NJ. Graft-versus-host disease. In: Burt RK, Deeg HJ, Lothian ST, et al, eds. Bone Marrow Transplant. Georgetown, Tex: Landes Bioscience;1996;478–98
- ↵Burt RK, Walsh TJ. Infection prophylaxix in bone marrow transplant recipients- myths, legends and microbes. In: Burt RK, Deeg HJ, Lothian ST, et al, eds. Bone Marrow Transplant. Georgetown, Tex: Landes Bioscience;1996 :438–51
- ↵Goodman WG, Danovitch GM. Options for patients with kidney failure. In: Danovitch GM, ed. Handbook of Kidney Transplantation 4th ed. Philadelphia: Lippincott Williams & Wilkins;2005 :1–22
- ↵Singer J, Gritsch HA, Rosenthal JT. The transplant operation and its surgical complications. In: Danovitch GM, ed. Handbook of Kidney Transplantation 4th ed. Philadelphia: Lippincott Williams & Wilkins;2005 :193–211
- ↵Katznelson S, Terasaki PI, Danovitch GM. Tissue typing, crossmatching and the allocation of cadaveric kidney transplants. In: Hakim NS, Danovitch GM, eds. Transplantation Surgery. London: Springer-Verlag;2001 :43–54
- ↵Halloran PF, Batiuk TD, Goes N, et al. Immunologic concepts. In: Stuart FP, Abecassis MM, Kaufman DB, eds. Organ Transplantation 2nd ed. Georgetown, Texas: Landes Bioscience;2003 :1–44
- ↵Kotb M. Bacterial pyrogenic exotoxins as superantigens. Clin Microbiol Rev 1995;8:411–26
- ↵Munford RS. Sepsis, severe sepsis and septic shock. In: Mandell GL, Bennett JE, Dolin R, eds. Principles and Practice of Infectious Diseases. Philadelphia: Elsevier;2005 :906–26
- ↵Keefe EB. Selection of patients for liver transplantation. In: Maddrey WC, Schiff ER, Sorrell MF, eds. Transplantation of the Liver. Philadelphia: Lippincott Williams & Wilkins;2001 :5–34
- Laffi G, Cominelli F, Ruggiero M, et al. Altered platelet function in cirrhosis of the liver: impairment of inositol lipid and arachidonic acid metabolism in response to agonists. Hepatology 1988;8:1620–26
- ↵
- ↵Xu M, Okajima H, Hubscher S, et al. Liver transplantation. In: Hakim NS, Danovitch GM, eds. Transplantation Surgery. London: Springer-Verlag;2001 :181–210
- ↵Everson GT, Kam I. Immediate postoperative care. In: Maddrey WC, Schiff ER, Sorrell MR, eds. Transplantation of the Liver 3rd ed. Philadelphia: Lippincott Williams & Wilkins;2001 :131–62
- ↵Borovikova LV, Ivanova S, Zhang M, et al. Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature 2000;405:458–62
- ↵Romanovsky AA, Ivanov AI, Szekely M. Neural route of pyrogen signaling to the brain. Clin Infect Dis 2000;31 Suppl 5:S162–67
- ↵Starzl TE, Demetris AJ, Trucco M, et al. Cell migration, chimerism, and graft acceptance, with particular reference to the liver. In: Busuttil RW, Klintmalm G, eds. Transplantation of the Liver. Philadelphia: WB Saunders;1996 :274–87
In this issue
Advertisement
Posterior Reversible Encephalopathy Syndrome after Solid Organ Transplantation
W.S. Bartynski, H.P. Tan, J.F. Boardman, R. Shapiro, J.W. Marsh
American Journal of Neuroradiology May 2008, 29 (5) 924-930; DOI: 10.3174/ajnr.A0960
Jump to section
Related Articles
Cited By...
- Pediatric Lung Transplantation
- Posterior Reversible Encephalopathy Syndrome as an Overlooked Complication of Induced Hypertension for Cerebral Vasospasm: Systematic Review and Illustrative Case
- Posterior reversible encephalopathy syndrome: the importance of early diagnosis
- The posterior reversible encephalopathy syndrome in HIV infection
- Hemorrhage in Posterior Reversible Encephalopathy Syndrome: Imaging and Clinical Features
This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.
- W.S. BartynskiAmerican Journal of Neuroradiology 2008 29 6
- W.S. BartynskiAmerican Journal of Neuroradiology 2008 29 6
- Marlene Fischer, Erich SchmutzhardJournal of Neurology 2017 264 8
- H.M. Hefzy, W.S. Bartynski, J.F. Boardman, D. LacomisAmerican Journal of Neuroradiology 2009 30 7
- Dimitre Staykov, Stefan SchwabJournal of Intensive Care Medicine 2012 27 1
- Molly M. Burnett, Christopher P. Hess, John P. Roberts, Nathan M. Bass, Vanja C. Douglas, S. Andrew JosephsonClinical Neurology and Neurosurgery 2010 112 10
- Archana HindujaFrontiers in Neurology 2020 11
- Alejandro A. Rabinstein, Jay Mandrekar, Ryan Merrell, Osman S. Kozak, Olayemi Durosaro, Jennifer E. FugateJournal of Stroke and Cerebrovascular Diseases 2012 21 4
More in this TOC Section
Similar Articles
Advertisement